News

RedHill Biopharma Receives $1.7 Million Grant for Opaganib Development

1 Mins read

Introduction

RedHill Biopharma announced on Friday that it has been awarded an additional $1.7 million in funding from the U.S. government. The funding comes in the form of a Small Business Innovation Research grant and will be given to its development partner, Apogee Biotechnology.

Advancing Opaganib as a Medical Countermeasure

This grant will support research to further the development of opaganib as a medical countermeasure for gastrointestinal acute radiation syndrome. RedHill Biopharma, a specialty biopharmaceutical company, believes that Opaganib has the potential to be an effective treatment for this condition.

Complementary to Existing Funding

It is important to note that this grant is in addition to the multimillion dollar-valued U.S. government Radiation and Nuclear Countermeasures Program product pipeline development contract already awarded to opaganib. The contract was given after the selection of opaganib by the RNCP for gastrointestinal acute radiation syndrome development.

Opaganib – A Game Changer

Opaganib is a novel, oral, small molecule pill with a remarkable five-year shelf-life. Its ease of administration and distribution make it an attractive option for potential central government stockpiling. If approved, it could play a crucial role in mass casualty nuclear radiation incidents.

Conclusion

RedHill Biopharma’s shares have experienced an 8% increase to $2 in premarket trading. The additional funding received through the Small Business Innovation Research grant will aid in advancing the development of opaganib as a medical countermeasure for gastrointestinal acute radiation syndrome.

Related posts
News

N. Korean tech workers faked IDs for overseas defense jobs

1 Mins read
N. Korean tech workers faked IDs for overseas defense jobs. April. 03, 2025 07:50. by 남혜정기자 [email protected]. North Korean cyberattacks involving the…
News

School curriculum resources to teach children about risks of in-game purchases

3 Mins read
The Oak National Academy – an arm’s length body to help schools deliver curriculum content – has launched a package of teaching…
News

Endeavour Silver is Producing First Batch of Concentrate at the Terronera Mine; Remains on Track for Wet Commissioning in Early Q2

3 Mins read
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) provides a…

Leave a Reply

Your email address will not be published. Required fields are marked *